142 related articles for article (PubMed ID: 9438458)
1. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
[TBL] [Abstract][Full Text] [Related]
2. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
[TBL] [Abstract][Full Text] [Related]
3. A feasibility study of the AutoPap system location-guided screening.
Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
[TBL] [Abstract][Full Text] [Related]
4. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
[TBL] [Abstract][Full Text] [Related]
5. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
Bibbo M; Hawthorne C; Zimmerman B
Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System.
Stevens MW; Milne AJ; James KA; Brancheau D; Ellison D; Kuan L
Diagn Cytopathol; 1997 Jun; 16(6):505-12. PubMed ID: 9181316
[TBL] [Abstract][Full Text] [Related]
7. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ; Dax Taylor D
Cancer; 1999 Dec; 87(6):354-8. PubMed ID: 10603189
[TBL] [Abstract][Full Text] [Related]
8. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
Wertlake P
J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
[TBL] [Abstract][Full Text] [Related]
9. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
Marshall CJ; Rowe L; Bentz JS
Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
[TBL] [Abstract][Full Text] [Related]
10. AutoPap 300 QC system scoring of cervical smears without "epithelial cell abnormalities".
Colgan TJ; Bon N; Lee JS; Patten SF
Acta Cytol; 1997; 41(1):45-9. PubMed ID: 9022725
[TBL] [Abstract][Full Text] [Related]
11. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory.
Colgan TJ; Patten SF; Lee JS
Acta Cytol; 1995; 39(6):1191-8. PubMed ID: 7483997
[TBL] [Abstract][Full Text] [Related]
12. Determining the utility and effectiveness of the NeoPath AutoPap 300 QC System used routinely.
Fetterman B; Pawlick G; Koo H; Hartinger J; Gilbert C; Connell S
Acta Cytol; 1999; 43(1):13-22. PubMed ID: 9987444
[TBL] [Abstract][Full Text] [Related]
13. Automated cervical cytology: meta-analyses of the performance of the AutoPap 300 QC System.
Abulafia O; Sherer DM
Obstet Gynecol Surv; 1999 Jul; 54(7):469-76. PubMed ID: 10394585
[TBL] [Abstract][Full Text] [Related]
14. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
Mango LJ; Valente PT
Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
[TBL] [Abstract][Full Text] [Related]
15. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.
Confortini M; Bonardi L; Bulgaresi P; Cariaggi MP; Cecchini S; Ciatto S; Cipparrone I; Galanti L; Maddau C; Matucci M; Rubeca T; Troni GM; Turco P; Zappa M; Carozzi F
Cancer; 2003 Jun; 99(3):129-34. PubMed ID: 12811852
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of the AutoPap 300 QC System for cervical cytologic abnormalities. Biopsy data confirmation.
Wilbur DC; Bonfiglio TA; Rutkowski MA; Atkison KM; Richart RM; Lee JS; Patten SF
Acta Cytol; 1996; 40(1):127-32. PubMed ID: 8604565
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
Huang TW; Lin TS; Lee JS
Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
[TBL] [Abstract][Full Text] [Related]
18. AutoPap system performance in screening for low prevalence and small cell abnormalities.
Lee JS; Wilhelm P; Kuan L; Ellison DG; Lei X; Oh S; Patten SF
Acta Cytol; 1997; 41(1):56-64. PubMed ID: 9022727
[TBL] [Abstract][Full Text] [Related]
19. The primary screening clinical trials of the TriPath AutoPap System.
Wilbur DC; Norton MK
Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
[TBL] [Abstract][Full Text] [Related]
20. A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
Sugiyama Y; Sasaki H; Komatsu K; Yabushita R; Oda M; Yanoh K; Ueda M; Itamochi H; Okugawa K; Fujita H; Tase T; Nakatani E; Moriya T
Acta Cytol; 2016; 60(5):451-457. PubMed ID: 27673689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
